[Network pharmacology study of effective constituents of traditional Chinese medicine for Alzheimer’s disease treatment].

This study aims to investigate the network pharmacology of Chinese medicinal formulae for treatment of Alzheimer’s disease.Machine learning algorithms were applied to construct classifiers in predicting the active molecules against 25 key targets toward Alzheimer’s disease(AD).By extensive data profiling, we compiled 13 classical traditional Chinese medicine(TCM) formulas with clinical efficacy for AD. There were 7 Chinese herbs with a frequency of 5 or higher in our study. Based on the predicted results, we built constituent-target, and further construct target-target interaction network by STRING(Search Tool for the Retrieval of Interacting Genes/Proteins) and target-disease network by DAVID(Database for Annotation,Visualization and Integrated Discovery) and gene disease database to study the synergistic mechanism of the herbal constituents in the Chinese traditional patent medicine. By prediction of blood-brain penetration and validation by TCMsp (traditional Chinese medicine systems pharmacology) and Drugbank, we found 7 typical multi-target constituents which have diverse structure. The mechanism uncovered by this study may offer a deep insight into the action mechanism of TCMs for AD. The predicted inhibitors for the AD-related targets may provide a good source of new lead constituents against AD.

[1]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[2]  C. Ung,et al.  Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? , 2003, Natural product reports.

[3]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[4]  Christian von Mering,et al.  STRING: a database of predicted functional associations between proteins , 2003, Nucleic Acids Res..

[5]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[6]  I. Melnikova Therapies for Alzheimer's disease , 2007, Nature Reviews Drug Discovery.

[7]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[8]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[9]  T. Wisniewski,et al.  Amyloid-β immunisation for Alzheimer's disease , 2008, The Lancet Neurology.

[10]  Calvin Yu-Chian Chen,et al.  Weighted Equation and Rules—A Novel Concept for Evaluating Protein-Ligand Interaction , 2009, Journal of biomolecular structure & dynamics.

[11]  Daniela Schuster,et al.  Identification of bioactive natural products by pharmacophore-based virtual screening. , 2010, Current pharmaceutical design.

[12]  D. Barlow,et al.  In silico search for multi-target anti-inflammatories in Chinese herbs and formulas. , 2010, Bioorganic & medicinal chemistry.

[13]  K. Blennow,et al.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.

[14]  Alan L Harvey,et al.  Current strategies for drug discovery through natural products , 2010, Expert opinion on drug discovery.

[15]  Kuan-Chung Chen,et al.  Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? , 2011, Molecular bioSystems.

[16]  Jerry Yang,et al.  Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors. , 2011, Bioorganic & medicinal chemistry.

[17]  Guang-Fu Yang,et al.  Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase. , 2012, Bioorganic & medicinal chemistry.

[18]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[19]  R. Armstrong A critical analysis of the 'amyloid cascade hypothesis'. , 2014, Folia neuropathologica.

[20]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[21]  Xingshu Li,et al.  Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease. , 2014, European journal of medicinal chemistry.

[22]  Rui Liu,et al.  Discovery of Multitarget-Directed Ligands against Alzheimer's Disease through Systematic Prediction of Chemical-Protein Interactions , 2015, J. Chem. Inf. Model..

[23]  Chenghua Gu,et al.  The Molecular Constituents of the Blood–Brain Barrier , 2015, Trends in Neurosciences.